The Haleon share price has woken up. Should I buy the FTSE 100 stock now?

FTSE 100 stock Haleon has shot up over the last month. Edward Sheldon is wondering if it could be a good addition to his portfolio.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

After largely trading sideways since its 2022 spin-off from GSK, the Haleon (LSE: HLN) share price is finally moving higher. Over the last month, the FTSE 100 stock has risen about 11%.

I’m looking for a bit more healthcare exposure right now as I like the sector from a risk/reward perspective. Could Haleon – which owns well-known consumer healthcare brands such as Sensodyne, Panadol, and Voltaren – be a good stock to buy for my portfolio? Let’s discuss.

Created with Highcharts 11.4.3Haleon Plc PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.co.uk

Performing well

Haleon’s recent half-year results were decent. For the six-month period to the end of June, the company saw:

Should you invest £1,000 in Rolls-Royce right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Rolls-Royce made the list?

See the 6 stocks

  • Organic revenue growth of 3.5%
  • ‘Power Brands’ organic growth of 5.6%
  • An 11% increase in adjusted operating profit
  • Free cash flow of £831m versus £369m a year earlier

On the back of these results, the company increased its H1 dividend by 11%. That’s a decent hike although the stock’s yield is only around 1.6% at the moment.

Looking ahead, Haleon provided new FY24 guidance. It now expects organic revenue growth to be between 4% and 6% and organic operating profit growth to be in the high single digits.

We are well positioned to deliver on our full year organic revenue growth guidance and now expect high-single digit organic profit growth. Given the successful delivery of the strategy to date Haleon is also well placed over the medium term.

CEO Brian McNamara

Overall, the results showed that the company has some momentum right now.

Any value on offer?

What about the valuation though?

Well, at present, City analysts expect Haleon to generate earnings per share of 18.1p this year and 19.6p next year.

So, at today’s share price of 375p, the forward-looking price-to-earnings (P/E) ratio here is 20.7, falling to 19.2 using next year’s earnings forecast.

It’s hard to know to think of those multiples, in my view.

On the one hand, Haleon owns a portfolio of top consumer healthcare brands and has relatively steady revenues. So, it probably deserves a premium valuation.

It’s worth noting that since the H1 numbers, analysts at Berenberg have raised their target price to 447p from 410p. That new target is nearly 20% above the current share price.

On the other hand, there’s quite a bit of debt on the company’s balance sheet. At 30 June, net debt was £8,415m, which equates to a net debt/EBITDA multiple of 2.9 (that’s relatively high).

One other risk here is consumer weakness. If consumers continue to rein-in spending, they could trade down to cheaper consumer healthcare brands.

Should I buy?

Weighing everything up, I’m going to hold off on buying Haleon shares for my portfolio for now.

I do think there’s a lot to like about this company from an investment perspective.

However, all things considered, I think there are better opportunities in the market for me today.

Of course, there are plenty of other passive income opportunities to explore. And these may be even more lucrative:

We think earning passive income has never been easier

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ed Sheldon has no position in any of the shares mentioned. The Motley Fool UK has recommended Haleon Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

6.8% dividend yield! Consider these 2 ‘secret’ passive income stocks to target a £1,360 payday in 2025

Looking for ways to generate above-average dividend income? These lesser-bought income stocks are worth a close look.

Read more »

Elevated view over city of London skyline
Investing Articles

The M&G dividend yields over 10% — and could get higher!

Christopher Ruane explains why he's upbeat about the long-term outlook for the M&G dividend yield and would happily buy the…

Read more »

Young Caucasian man making doubtful face at camera
Investing Articles

2 popular UK growth stocks I wouldn’t touch with a bargepole in today’s market

Buying growth stocks can deliver market-beating returns, but this FTSE 250 pair doesn't look like a convincing investment for our…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

10 FTSE shares falling today after President Trump’s tariffs bombshell!

Our writer explains why JD Sports Fashion from the FTSE 100 and a diverse bunch of other UK stocks are…

Read more »

Fans of Warren Buffett taking his photo
Investing Articles

With value investing back in vogue, I’m taking a leaf out of Warren Buffett’s playbook

With tariffs and trade wars resulting in heightened market volatility, Andrew Mackie takes comfort in Warren Buffett’s words of wisdom.

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

Around a 1-year high, is there enough value left in Next’s share price to make it worth me buying?

Next’s share price has risen a lot in eight months, but there could still be a lot of value left…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

OMG DYOR but IMO this ‘cool’ FTSE 100 stock offers bangin’ VFM!

Despite being one of the least trendy 50-somethings around, our writer considers how Gen Z could help push this FTSE…

Read more »

Investing Articles

2 cheap FTSE 100 and FTSE 250 growth stocks to consider as stock markets sink

I think these Footsie and FTSE 250 growth shares could be very shrewd buys to consider in the current climate.…

Read more »